# ROX Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rox-medical

- Industry: Medical Devices & Equipment
- Headquarters: San Clemente, US
- Website: www.roxmedical.com
- Total disclosed funding: $93M
- Latest round: Series E (Sep 6, 2016)
- Investors on record: 6

## About

ROX Medical is a medical technology company focused on developing innovative solutions for managing chronic kidney disease through advanced therapeutic options and operational efficiencies in patient care.ROX Medical, founded in 2004, is headquartered in San Clemente, US. The company specializes in advanced medical devices aimed at improving renal health. Notably, in September 2016, the company secured USD 40 mn in SERIES E funding led by Apple Tree Partners and Novartis Venture Fund, with participation from Domain Associates and Versant Ventures, marking its seventh deal. The founders, John Faul and Rodney Brenneman, have not been reported to have founded other companies prior to ROX Medical.ROX Medical specializes in delivering innovative technology solutions aimed at optimizing operational efficiency in the healthcare sector. Their core products include advanced medical devices designed for the management of chronic kidney disease. These devices utilize cutting-edge technology to provide efficient treatment options that enhance patient care. Their offerings cater to hospitals and healthcare providers looking to improve patient outcomes and streamline operations. ROX Medical's products have been launched in various markets, including North America, Europe, and parts of Asia, responding to the needs of healthcare institutions for effective kidney disease management.ROX Medical's revenue model is based on a combination of subscription-based services and direct sales of their medical devices to healthcare providers. Clients typically engage in multi-year contracts, gaining access to devices and ongoing support. The company collaborates with channel distributors and healthcare system integrators to effectively reach target customers. Pricing plans are tailored to accommodate different sizes of healthcare providers, emphasizing the value of their innovative devices to maximize return on investment and maintain long-term partnerships.ROX Medical intends to leverage the recent funding of USD 40 mn from its SERIES E round to further develop its product offerings and expand its market reach. The company is currently designing new medical devices aimed at enhancing the management of chronic kidney disease, with expected launches in the coming years. Additionally, ROX Medical plans to penetrate new geographic regions, particularly in Asia and Europe, by 2025, to grow its presence in the global healthcare market.

## Funding rounds

- Series E, Sep 6, 2016, $40M — Domain Associates, Versant Ventures, Novartis Venture Fund, Apple Tree Partners
- Series D, Sep 6, 2012, $6M — Domain Associates, Versant Ventures
- Series C, May 27, 2008, $33M — Domain Associates, Essex Woodlands, Prism Venture Management, Versant Ventures
- Series B, Jul 19, 2006, $10M — Domain Associates, Prism Venture Management, Versant Ventures
- Series A, Apr 6, 2004, $3.6M — Prism Venture Management, Versant Ventures

## Investors

- Prism Venture Management (https://capitalatlas.ai/funds/prism-venture-management) — Series A, Series B, Series C
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A, Series B, Series C, Series D, Series E
- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B, Series C, Series D, Series E
- Essex Woodlands (https://capitalatlas.ai/funds/essex-woodlands) — Series C
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series E
- Apple Tree Partners (https://capitalatlas.ai/funds/apple-tree-partners) — Series E